发明名称 |
Tetrazolo hydrazine derivatives and pharmaceutical composition comprising same as active ingredient for preventing or treating cancer |
摘要 |
Provided are novel tetrazolo hydrazone derivatives or pharmaceutically acceptable salts thereof. The derivatives and the salts may inhibit the proliferation of cancer cells in a low molar concentration and inhibit the activity of cancer cells through the regulation of expression of apoptosis-related genes or the like, thus expressing excellent anti-cancer activity, and therefore, can be used effectively in preventing or treating cancer. |
申请公布号 |
US9206165(B2) |
申请公布日期 |
2015.12.08 |
申请号 |
US201314419531 |
申请日期 |
2013.08.06 |
申请人 |
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YEUNGNAM UNIVERSITY |
发明人 |
Choi In Ho;Fareeda Athar;Abdul Roouf Bhat |
分类号 |
C07D405/04;A61K31/41 |
主分类号 |
C07D405/04 |
代理机构 |
Cantor Colburn LLP |
代理人 |
Cantor Colburn LLP |
主权项 |
1. Tetrazolo hydrazone derivatives represented by the following Formula 1 or pharmaceutically acceptable salts thereof: wherein, R1, R2, R3, R4 and R5 are independently H, halogen, NO2, C1-4 alkyl, C1-4 haloalkyl or C1-4 alkoxy. |
地址 |
KR |